Empagliflozin 10 mg – 25 mg
Image
Product Description
- A sodium-glucose transporter 2 inhibitor (SGLT2i) that is indicated to lower blood glucose level in type 2 diabetes patients.
- Highly effective treatment for type type 2 diabetes at any disease stage.
- Has cardioprotective benefits and significantly reduces cardiovascular deaths and hospitalizations.
- Has Reno protective benefits and improves renal outcomes.
- Has weight-reduction effect and low risk of hypoglycemia